Otolaryngology Doctors in Manahawkin, NJ Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Albert Poet, M.D. Otolaryngology - Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 703 Mill Creek Rd, Suite G, Manahawkin, NJ 08050 Phone: 609-597-6800    Fax: 609-597-5282

Dr. Lynn E Bezpalko, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 77 Nautilus Dr, Manahawkin, NJ 08050 Phone: 609-597-0321    Fax: 609-597-0014

Dr. Edward I Engle, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1145 Beacon Avenue, Manahawkin, NJ 08050 Phone: 609-597-7110    Fax: 609-597-7113

Dr. Bruce J Romanczuk, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1145 Beacon Avenue, Manahawkin, NJ 08050 Phone: 609-597-7110    Fax: 609-597-7113

Dr. Orest Bezpalko, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 77 Nautilus Dr, Manahawkin, NJ 08050 Phone: 609-597-0321    Fax: 609-597-0014

News Archive

Incept completes first U.S. human clinical trial of SMART Start Embryo Culture System

Incept BioSystems, Inc. a privately-held biomedical device company using patented, microfluidic technology developed at the University of Michigan, announced today the completion of the first U.S. human clinical trial of its proprietary, SMART Start Embryo Culture System, and the recent submission of a 510(k) application to the U.S. Food & Drug Administration.

Study reveals new broadly neutralizing and protective antibody against coronaviruses

In the setting of potentially reduced vaccine efficacy against coronavirus disease (COVID-19) due to emerging viral variants, the deployment of effective treatments based on monoclonal antibodies may be an additional strategy to help control the pandemic. A new study by US researchers, currently available on the bioRxiv* preprint server, describes the action of a specific antibody known as DH1047.

Researchers discover Achilles heel of common bacteria that causes fatal infections

Pseudomonas aeruginosa is a common bacterium of our environment. It can however become a formidable pathogen causing fatal infections, especially in intubated patients, people suffering from cystic fibrosis or severe burns.

Reduced incidence of invasive breast cancer with Raloxifene among women at increased coronary risk

Women who took raloxifene were less likely to develop invasive estrogen-receptor (ER) positive breast cancer compared with women who did not, according to data from a randomized controlled trial published online June 10 in the Journal of the National Cancer Institute. The drug did not reduce the risk of non-invasive cancer or invasive ER-negative cancers.

New method to target and destroy cancerous cells using hyperthermia

Using hyperthermia, Virginia Tech engineering researchers and a colleague from India unveiled a new method to target and destroy cancerous cells. The research was presented at the 63rd annual meeting of the American Physical Society Nov. 23 in Long Beach, Calif.

Read more Medical News

› Verified 6 days ago